HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsuyoshi Saito Selected Research

Adenocarcinoma

11/2023Frequent nuclear β-catenin expression in pulmonary enteric-type adenocarcinoma according to the current World Health Organization criteria.
9/2023Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
12/2022Pathological classification of desmoplastic reaction is prognostic factor in cervical adenocarcinoma.
11/2022Low-grade tracheal adenocarcinoma with ETV6::NTRK3 fusion: unique morphology akin to subsets of sinonasal low-grade non-intestinal-type adenocarcinoma.
4/2022Aberrant expression of claudin-6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma.
4/2022Mucin phenotypes and clinicopathological features of colorectal adenocarcinomas: Correlation with colorectal adenocarcinoma with enteroblastic differentiation.
2/2021Aberrant expression of junctional adhesion molecule-A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155.
11/2020Possibility of Targeting Claudin-2 in Therapy for Human Endometrioid Endometrial Carcinoma.
9/2020Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation.
8/2020Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tsuyoshi Saito Research Topics

Disease

144Neoplasms (Cancer)
01/2024 - 01/2002
35Breast Neoplasms (Breast Cancer)
01/2024 - 02/2003
35Adenocarcinoma
11/2023 - 03/2002
27Endometrial Neoplasms (Endometrial Cancer)
01/2024 - 03/2002
20Neoplasm Metastasis (Metastasis)
03/2023 - 07/2005
19Carcinoma (Carcinomatosis)
09/2023 - 10/2003
18Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2023 - 04/2006
15Sarcoma (Soft Tissue Sarcoma)
11/2023 - 11/2004
12Carcinogenesis
11/2020 - 03/2002
11Ovarian Neoplasms (Ovarian Cancer)
10/2018 - 01/2008
10Synovial Sarcoma (Synovioma)
01/2013 - 04/2002
8Insulin Resistance
09/2023 - 04/2007
8Adenocarcinoma of Lung
04/2023 - 01/2013
7Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2024 - 10/2011
7Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 02/2010
7Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
09/2011 - 01/2002
7Endometrial Hyperplasia
07/2007 - 03/2002
6Hemorrhage
03/2024 - 01/2010
6Microsatellite Instability
01/2024 - 09/2003
6Adenoma (Adenomas)
01/2023 - 07/2009
6Rupture
04/2020 - 04/2006
6Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2014 - 12/2006
5Placenta Accreta
03/2024 - 01/2010
5Hyperplasia
01/2024 - 03/2002
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2023 - 01/2004
5Stomach Neoplasms (Stomach Cancer)
01/2023 - 07/2005
5Giant Cell Tumors (Giant Cell Tumor)
01/2019 - 01/2004
4Leiomyosarcoma
06/2023 - 10/2004
4Ovarian Hyperstimulation Syndrome
12/2022 - 02/2006
4Endometriosis
12/2021 - 06/2002
4Mucinous Adenocarcinoma (Mucinous Carcinoma)
06/2021 - 01/2014
4Lymphatic Metastasis
01/2021 - 01/2013
4Ovarian Epithelial Carcinoma
01/2015 - 08/2012
3Peripheral Nervous System Diseases (PNS Diseases)
12/2022 - 01/2017
3Lung Neoplasms (Lung Cancer)
03/2022 - 09/2016
3Fatigue
01/2022 - 01/2016
3Infections
12/2021 - 01/2012

Drug/Important Bio-Agent (IBA)

49Proteins (Proteins, Gene)FDA Link
01/2024 - 07/2002
17Biomarkers (Surrogate Marker)IBA
11/2023 - 02/2012
14CateninsIBA
11/2023 - 06/2011
12Trastuzumab (Herceptin)FDA Link
12/2022 - 08/2015
11Cadherins (E-Cadherin)IBA
10/2018 - 02/2003
10Hormones (Hormone)IBA
01/2024 - 08/2007
10Phosphotransferases (Kinase)IBA
11/2023 - 02/2007
10ParaffinIBA
10/2023 - 09/2002
10MucinsIBA
01/2023 - 10/2012
10beta CateninIBA
12/2018 - 01/2002
9DNA (Deoxyribonucleic Acid)IBA
11/2023 - 03/2002
8Formaldehyde (Formol)FDA Link
10/2023 - 09/2002
8Estrogen ReceptorsIBA
10/2021 - 01/2008
8Paclitaxel (Taxol)FDA LinkGeneric
06/2018 - 08/2003
7ErbB Receptors (EGF Receptor)IBA
01/2023 - 08/2012
7Estrogens (Estrogen)FDA Link
12/2022 - 03/2002
7CollagenIBA
12/2022 - 08/2003
7Tight Junction ProteinsIBA
12/2021 - 02/2006
7Messenger RNA (mRNA)IBA
04/2021 - 01/2002
7Small Interfering RNA (siRNA)IBA
11/2020 - 08/2010
7Insulin (Novolin)FDA Link
08/2019 - 08/2007
6AndrogensIBA
09/2023 - 06/2010
6eribulinFDA Link
06/2023 - 01/2016
6Indicators and Reagents (Reagents)IBA
12/2022 - 02/2002
6Progesterone Receptors (Progesterone Receptor)IBA
10/2021 - 03/2004
6AdiponectinIBA
03/2018 - 04/2007
6Matrix Metalloproteinases (MMPs)IBA
12/2017 - 06/2002
6AntibodiesIBA
10/2016 - 02/2007
5taxaneIBA
12/2022 - 01/2016
5Therapeutic UsesIBA
05/2022 - 08/2014
5Lipoprotein Receptors (Lipoprotein Receptor)IBA
12/2021 - 05/2016
4tyrosine receptor (receptor, tyrosine)IBA
11/2023 - 01/2017
4RNA (Ribonucleic Acid)IBA
11/2023 - 04/2021
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2023 - 10/2020
4MicroRNAs (MicroRNA)IBA
03/2023 - 09/2014
4130-nm albumin-bound paclitaxelIBA
12/2022 - 02/2021
4Transcription Factors (Transcription Factor)IBA
03/2022 - 10/2004
4ClaudinsIBA
12/2021 - 06/2011
4Tyrosine Kinase InhibitorsIBA
10/2021 - 05/2020
4HLA Antigens (Human Leukocyte Antigens)IBA
10/2020 - 12/2014
4DenosumabFDA Link
01/2020 - 12/2014
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2014 - 05/2005
4SYT-SSX fusion proteinIBA
01/2013 - 05/2004
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2024 - 11/2011
3Epidermal Growth Factor (EGF)IBA
01/2024 - 08/2012
3Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2024 - 09/2012
3Thyroid Nuclear Factor 1IBA
04/2023 - 01/2021
3Monoclonal AntibodiesIBA
01/2023 - 02/2007
3Immune Checkpoint InhibitorsIBA
05/2022 - 10/2016
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2004

Therapy/Procedure

50Therapeutics
01/2024 - 01/2004
32Drug Therapy (Chemotherapy)
11/2023 - 01/2004
14Trachelectomy
01/2021 - 04/2006
11Radiotherapy
03/2023 - 01/2004
7Hysterectomy
10/2023 - 01/2004
5Precision Medicine
01/2023 - 09/2016
5Neoadjuvant Therapy
01/2023 - 01/2004
5Cervical Cerclage
07/2021 - 12/2013
4Immunotherapy
11/2023 - 02/2012
4Lasers (Laser)
11/2023 - 07/2002
4Chemoradiotherapy
03/2023 - 08/2020
4Cesarean Section (Caesarean Section)
03/2021 - 04/2006
4Lymph Node Excision (Lymph Node Dissection)
04/2020 - 07/2016